Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Cardiome Pharma Corp. (OTC BB:COMTF.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile
Location
3650 Wesbrook Mall
British Columbia, V6S 2L2
Vancouver, Canada
Phone: (604) 222-5577
Fax: (604) 222-6617
Email: mmidmer@nortran.com
Employees (last reported count): 32
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 25%
·Institutional: 1% (1% of float)
(2 institutions)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Cardiome Pharma Corporation, formerly known as Nortran Pharmaceuticals Inc., is a drug discovery company engaged in the treatment of pathologies and conditions which are mediated by cellular ion channels. The Company's primary focus is the discovery and development of drugs designed to prevent cardiac arrhythmias and for the treatment of acute unproductive cough. To date, the Company has not yet determined the ultimate economic viability of the drugs and has not commenced commercial operations for its drugs.
More from Market Guide: Expanded Business Description

Financial Summary
Cardiome Pharma Corp. is a pharmaceutical company whose primary focus is the development of targeted small molecules for the treatment of life-threatening cardiac arrhythmias. For the six months ended 5/31/01, revenues rose 22% to C$357 thousand. Net loss rose 62% to C$4.1 million. Revenues reflect higher grant income and increased interest income due to higher average cash balances. Higher loss reflects increased costs related to the RSD 1235 clinical trial.
More from Market Guide: Significant Developments

Officers
FY1999 Pay

Michael Walker, Ph.D.
Chairman
--  
Robert Rieder
Pres, CEO
$200K
Gregory Beatch
VP - Research
125K
Sheila Grant
Sec. of Fin. and Admin.
--  
Dollar amounts are as of 30-Nov-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:COMTF.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-Dec-2000
$0.281
Recent Price$0.40 
52-Week High
on 16-Oct-2000
$2.25 
Beta-0.82 
Daily Volume (3-month avg)2,500 
Daily Volume (10-day avg)1,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-58.7%
52-Week Change
relative to S&P500
-44.6%
Share-Related Items
Market Capitalization$16.5M
Shares Outstanding41.2M
Float30.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.12 
Earnings (ttm)-$0.10 
Earnings (mrq)-$0.04 
Sales (ttm)$0.04 
Cash (mrq)$0.10 
Valuation Ratios
Price/Book (mrq)3.21 
Price/EarningsN/A 
Price/Sales (ttm)9.11 
Income Statements
Sales (ttm)$1.80M
EBITDA (ttm)-$3.26M
Income available to common (ttm)-$3.91M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsNov 30
Most recent quarter31-May-2001
Management Effectiveness
Return on Assets (ttm)-48.45%
Return on Equity (ttm)-51.80%
Financial Strength
Current Ratio (mrq)11.63 
Debt/Equity (mrq)0.00 
Total Cash (mrq)$4.07M
Short Interest
Shares ShortN/A 
See Profile Help for a description of each item above;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-May-2001);   dollar amounts based on an exchange rate of 1.55 Canadian Dollars/US Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.